MKI67 and digestive system mixed adenoneuroendocrine carcinoma: Treating according to the more aggressive component of the tumor appears to be reasonable considering the fact that the aggressiveness of the neuroendocrine component of MANEC is based on the mitotic index and the Ki-67 proliferation index (3).